J2HBiotech
Latest round
- Series C
Last raised
- Jun 2020
Total raised
- $25M
Investors
- 14
About J2HBiotech
Founded in 2014 and based in Suwon, South Korea, J2HBiotech is a biopharmaceutical company that focuses on the research and development of Non-Alcoholic Steatohepatitis (NASH) pharmaceuticals. In 2017, the company won a patent lawsuit for a new hepatitis B improvement drug. In 2018, the company established its third factory. In 2019, the company was selected as a preliminary unicorn company. The company's main products include drugs J2H-1701, J2H-1801, J2H-1908 and J2H-PROTAC, etc. The company's products are used in diseases such as amyotrophic lateral sclerosis, liver fibrosis, multiple sclerosis and tumors.
Who invested in J2HBiotech
14 investors across 3 rounds
See all investors in J2HBiotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about J2HBiotech
Who invested in J2HBiotech?
J2HBiotech has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has J2HBiotech raised?
J2HBiotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did J2HBiotech last raise money?
J2HBiotech's most recent round on record is a Series C, in Jun 2020.
What does J2HBiotech do?
Founded in 2014 and based in Suwon, South Korea, J2HBiotech is a biopharmaceutical company that focuses on the research and development of Non-Alcoholic Steatohepatitis (NASH) pharmaceuticals.
Where is J2HBiotech headquartered?
J2HBiotech is headquartered in Suwon, South Korea.
Which VCs invest in companies like J2HBiotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at J2HBiotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like J2HBiotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.